CAR-T Cell therapy – general information:

CAR-T cell therapy is an innovative method for treating certain types of blood cancers, in which a patient’s own white blood cells are genetically modified to target and destroy cancer cells. Advanced technology is used to separate white blood cells (which are a crucial part of the immune system) from the rest of the blood. In a specialized laboratory, these white blood cells are genetically modified to express chimeric antigen receptors (CAR). In the next stage, they are multiplied in the laboratory until millions of modified cells are obtained and then returned to the patient.

CAR-T cells are reintroduced into the patient’s bloodstream through infusion. The chimeric antigen receptors will now help the genetically modified cells to bind with the specific antigens on the cancer cells, effectively hunting them down and destroying them.

Benefits of CAR-T Therapy:

When other treatments for blood cancers have proven ineffective, CAR-T cell therapy can yield desired results and, in some cases, lead to disease remission. A significant advantage of this type of therapy is that CAR modification not only causes T cells to kill the tumor but also initiates their division and growth. As a result, after a single treatment, CAR-T cells remain in your body and continue to attack the tumor for months or even years.

CAR-T cell therapy is a highly specialized and personalized treatment that is not widely available worldwide. Oncologists in Israel have been trained at leading medical institutions and have been involved in the development of this method. That is why our EMAS team is honored to offer you this innovative therapy.